Medidata Solutions to Lead Sessions at Key Global Events in February

FOR IMMEDIATE RELEASE
 

Clinical Trial Technology Executives Share Expertise on Regulatory Challenges,
Trial Planning and Late Phase at Conferences in the U.S., U.K. and Japan

NEW YORK, N.Y. – February 1, 2010 – Medidata Solutions (NASDAQ: MDSO), a leading global provider of hosted clinical development solutions, today announced that members of its management team will deliver the following presentations at key industry events in February:
13th Annual Workshop in Japan for Clinical Data Management
February 4–5, 2010, Tokyo, Japan
Presentation: “Being Prepared for Regulatory Inspection of EDC System”
Speaker: Fran Nolan, Vice President, Quality Assurance
Date & Time: Friday, February 5, 3:30 p.m. JST

Japanese CDM activities are not different from U.S./EU in processes and technologies. However, there might be major differences in the approaches to policy and strategic issues. This meeting will focus on priorities for the Japan market, how goals can be achieved, how to succeed in the next generation and what improvements can be made currently. To learn more, please visit www.diahome.org.

3rd Annual Clinical Trial Budgeting and Forecasting Conference
February 8–9, 2010, Philadelphia, PA, U.S.
Presentation: “Capacity Planning and Vendor Selection”
Speaker: Lori Shields, Vice President, Data Operations
Date & Time: Tuesday, February 9, 9:00 a.m. EST

While pharmaceutical companies are spending more resources on clinical trials to ensure quality drugs in the pipeline and average length of a clinical trial is growing, it is critical for industry thought leaders to discuss new tools and industry methodologies used to accurately assess budget development for R&D initiatives. This conference is an opportunity to share issues and solutions that intersect both financial planning and clinical operations, in order to improve time to market, quality and financial performance of clinical trials. To learn more, please visit www.cbinet.com.

6th Annual Forum on Late Phase Research, Drug Safety and Risk Management
February 2–26, 2010, London, U.K.
Presentation: “Enhance Site Recruitment, Retention and
Satisfaction in Post-Marketing Studies”
Speaker: Patrick Chassaigne, Director, Late Phase Solutions
Date & Time: Friday, February 26, 9:30 a.m. BST

This event will bring together industry thought leaders to examine the evolving landscape for late phase studies and discuss new challenges and opportunities within Phase IV and observational studies. Topics for this event include, drug safety, adverse event reporting, active surveillance, patient recruitment/retention, publication planning and health economics. To learn more, please visit www.cbinet.com.
About Medidata Solutions Worldwide
Medidata Solutions (www.mdsol.com) is a leading global provider of hosted clinical development solutions that enhance the efficiency of customers’ clinical development processes and optimize their research and development investments. Medidata products and services allow customers to achieve clinical results more efficiently and effectively by streamlining the design, planning and management of key aspects of the clinical development process, including protocol development (Medidata Designer®), investigator benchmarking and budgeting (Medidata Grants Manager™), contract research organization (CRO) benchmarking and budgeting (Medidata CRO Contractor™), and the capture, management, analysis and reporting of clinical trial data (Medidata Rave®). Medidata’s diverse customer base spans pharmaceutical, biotechnology and medical device companies, academic institutions, CROs and other research organizations, and includes more than 20 of the top 25 global pharmaceutical companies.

Contact:
Susan McCarron
Lois Paul & Partners
781.782.5767
Susan_McCarron@lpp.com